Condition
B-NHL clinical trials and research
As of November 12, 2026, Find a Trial lists 4 B-NHL clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest B-NHL clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Comparing immunotherapy bridging treatment to standard therapy in low-risk B-NHL patients | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 19, 2024 |
| JY231 injection for relapsed or refractory B‑cell lymphoma and leukemia | — | Wuhan, Hubei | Recruiting | Nov 15, 2024 |
| JY231 injection for treating relapsed or refractory B cell lymphoma and leukemia | — | Zhenzhou, Henan | Recruiting | Nov 7, 2024 |
| New CAR T-cell therapy for children and young adults with certain blood cancers | Phase 1/2 | Bethesda, Maryland | Recruiting | Jul 5, 2022 |
All recruiting trials (4)
-
Comparing immunotherapy bridging treatment to standard therapy in low-risk B-NHL patients
This study is testing whether adding an immunotherapy treatment with zanubrutinib helps people with low-risk B-cell non-Hodgkin lymphoma feel better compared to those who don’t get this extra treatment.
-
JY231 injection for relapsed or refractory B‑cell lymphoma and leukemia
This trial will test whether a single intravenous JY231 injection, given with or without short lymphodepletion, can help adults with relapsed or refractory CD19‑positive B‑cell lymphoma or B‑ALL.
-
JY231 injection for treating relapsed or refractory B cell lymphoma and leukemia
This study is testing a new injection called JY231 to see if it can help people with relapsed or hard-to-treat B cell lymphoma and leukemia feel better.
-
New CAR T-cell therapy for children and young adults with certain blood cancers
This study is testing a new CAR T-cell therapy that uses modified cells from children's and young adults' own blood to see if it can help treat certain tough-to-treat blood cancers.
Related topics
Quick answers
How many B-NHL clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.